title: Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
abstract: Type 1 diabetes induces several metabolic and biochemical disturbances which result in the alteration ofNa,K-ATPase, an enzyme implicated in the physiopathology of neuropathy Several fatty acid supplementations lessen this alteration. The aims of this study were to determine the possible relationships between Na,K-ATPase activity in nerves and red blood cells (RBCs) and, on one hand, the fatty acid alterations induced by diabetes in these tissues and plasma and on the other, on nerve physiological parameters. Two groups of rats, control and diabetic (n = 15), were sacrified 8 weeks after induction of diabetes with streptozotocin. Nerve conduction velocity (NCV), nerve blood flow (NBF), Na,K-ATPase activity and membrane fatty acid composition of sciatic nerves, red blood cells (RBCs) and plasma were measured. NCV, NBF and Na,K-ATPase activity in RBCs and in sciatic nerves were significantly decreased in diabetic rats. We revealed a positive correlation between Na,K-ATPase activity in sciatic nerves and both NBF and NCV and between Na,K-ATPase activity in RBCs and NBF and the same activity in sciatic nerve. Diabetes induced major changes in plasma fatty acids and RBC membranes and less important changes in sciatic nerve membranes. Na,K-ATPase activity correlated negatively with C20: 4 (n-6) and C22: 4 (n-6) levels in nerves and with C18: 2 (n-6) levels in RBCs. During diabetes, changes in the membrane fatty acid composition suggest the existence of a tissue-specific regulation, and the decrease in Na,K-ATPase activity correlates with the alteration in the level of specific fatty acids in RBCs and sciatic nerves. Modifications in the lipidic environment of Na,K-ATPase would be involved in the alteration of its activity. Na,K-ATPase activity seems to be implicated in the decrease of both NCV and NBF during diabetes.
authors.affiliation: Faculté de Médecine, Service de Diabétologie UPRES EA2193, Marseille, France. anissadjemli@voila.fr
authors.forename: A
authors.initials: A
authors.lastname: Djemli-Shipkolye
authors.forename: T
authors.initials: T
authors.lastname: Coste
authors.forename: D
authors.initials: D
authors.lastname: Raccah
authors.forename: P
authors.initials: P
authors.lastname: Vague
authors.forename: G
authors.initials: G
authors.lastname: Pieroni
authors.forename: A
authors.initials: A
authors.lastname: Gerbi
mesh_terms: D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology / Q000503:physiopathology*; D004910:Erythrocyte Membrane / Q000737:chemistry; D004912:Erythrocytes / Q000201:enzymology / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood / Q000378:metabolism; D006801:Humans; D050356:Lipid Metabolism; D008297:Male; D009431:Neural Conduction; D051381:Rats; D017207:Rats, Sprague-Dawley; D012039:Regional Blood Flow; D012584:Sciatic Nerve / Q000098:blood supply / Q000201:enzymology / Q000503:physiopathology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D013223:Statistics as Topic
chemical_list: D005227:Fatty Acids; D000254:Sodium-Potassium-Exchanging ATPase